Gjølberg TT, Mester S, Calamera G, Telstad JS, Sandlie I, Andersen JT(2025) Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress BioDrugs(in press) DOI 10.1007/s40259-025-00708-2, PubMed 40156757
Mester S, Chan C, Lustig M, Foss S, Jansen JHM, Leangen Herigstad M, Evers M, Nilsen J, Reiding KR, A Damen JM, Burger R, Grevys A, Dalhus B, Valerius T, Sandlie I, Leusen JHW, Andersen JT(2025) Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life PNAS Nexus, 4(2), pgaf042 DOI 10.1093/pnasnexus/pgaf042, PubMed 40041621
Pilati D, Agyei EK, Elkhashab M, Fuchs E, Nielsen IH, Bjerg TW, Anthi AK, Jiménez-Reinoso A, Iversen MB, Pohl L, Narita R, Frago S, Jakobsen MR, Andersen JT, Degn SE, Paludan SR, Alvarez-Vallina L, Howard KA(2025) Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction J Biol Chem, 108508(in press) DOI 10.1016/j.jbc.2025.108508, PubMed 40222546
